Editorial: Fibromyalgia: Where are we a decade after the American College of Rheumatology classification criteria were developed?

Arthritis and Rheumatism

Volumn 46, Issue 5, 2002, Pages 1136-1138

  Crofford, Leslie J ^a,c   Clauw, Daniel J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c MSRB I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUBSTANCE P;

BRAIN BLOOD FLOW; EDITORIAL; FIBROMYALGIA; HUMAN; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NOCICEPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNDROME DELINEATION; THALAMUS; CLASSIFICATION; MEDICAL SOCIETY; RHEUMATOLOGY; UNITED STATES;

FIBROMYALGIA; HUMANS; RHEUMATOLOGY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0036562449     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10217     Document Type: Editorial

References (29)

1. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee
2. Increased pain sensitivity in fibromyalgia: Effect of two types of stimuli and ascending versus random modes of presentation
3. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome
4. Repetitive muscle stimuli result in enhanced wind-up of fibromyalgia patients
5. Psychological and neural mechanisms of the affective dimension of pain
6. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome
7. Fibromyalgia in women: Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels
8. Pain sensitivity and bilateral activation of brain structures during pressure stimulation of patients with fibromyalgia (FM) is not mediated by major depression (DEP)
9. FMRI evaluation of pain intensity coding in fibromyalgia patients and controls
10. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis
11. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome
12. Elevated substance P levels are contrasted by a decrease in met-enkephalin-arg-phe levels in CSF from fibromyalgia patients
13. Abnormal brain regional cerebral blood flow (rCBF) and cerebrospinal fluid (CSF) levels of substance P (SP) in patients and non-patients with fibromyalgia (FM)
14. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia
15. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome
16. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain
17. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome
18. Orthostatic sympathetic derangement in subjects with fibromyalgia
19. Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis
20. Orthostatic sympathetic derangement of baroreflex in patients with fibromyalgia
21. Sympathetic nervous system function in fibromyalgia
22. Abnormal sympathovagal balance in men with fibromyalgia
23. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia
24. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia
25. Pain, disability, and pain/disability relationships in seven rheumatic disorders: A study of 1,522 patients
26. Self-report questionnaires in five rheumatic diseases: Comparisons of health status constructs and associations with formal education level
27. Measuring the epidemiology of distress: The rheumatology distress index
28. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms
29. The overlap between fibromyalgia and inflammatory rheumatic diseases: When and why does it occur?